Two Sigma Investments’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.27M Sell
241,392
-2,895,628
-92% -$34.6M ﹤0.01% 2549
2026
Q1
$18.8M Buy
3,137,020
+966,544
+45% +$7.27M 0.02% 985
2025
Q4
$15.6M Buy
2,170,476
+1,529,117
+238% +$12.1M 0.02% 853
2025
Q3
$6.85M Buy
641,359
+484,959
+310% +$4.76M 0.01% 1213
2025
Q2
$1.51M Buy
+156,400
New +$1.61M ﹤0.01% 2010
2023
Q2
Sell
-9,500
Closed -$223K 3197
2023
Q1
$223K Sell
9,500
-112,739
-92% -$3.03M ﹤0.01% 2522
2022
Q4
$3.41M Buy
+122,239
New +$3.13M 0.01% 1052
2022
Q1
Sell
-29,375
Closed -$894K 3833
2021
Q4
$894K Buy
29,375
+800
+3% +$26.1K ﹤0.01% 2663
2021
Q3
$937K Sell
28,575
-12,501
-30% -$400K ﹤0.01% 2674
2021
Q2
$1.24M Buy
+41,076
New +$1.35M ﹤0.01% 2289

Other funds holding OGN

Two Sigma Investments's OGN Position: Q2 2026 in Review

Two Sigma Investments reduced its Organon & Co (OGN) stake by 92% in Q2 2026, selling an estimated $34.6M and leaving 241,392 shares worth $3.27M. The position accounts for ﹤0.01% of the portfolio, ranked #2549.

Two Sigma Investments first reported a position in OGN in Q2 2021 and has held it in 10 quarters since. The position peaked at $18.8M in Q1 2026. 627 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Two Sigma Investments held 241,392 shares of Organon & Co worth $3.27M as of Q2 2026.
  • Two Sigma Investments sold 2,895,628 Organon & Co shares in Q2 2026, an estimated $34.6M.
  • Organon & Co made up ﹤0.01% of Two Sigma Investments's portfolio in Q2 2026, its #2549 holding.
  • Two Sigma Investments first reported a position in Organon & Co in Q2 2021 and has held it in 10 quarters since.
  • Two Sigma Investments's Organon & Co position peaked at $18.8M in Q1 2026.
  • 627 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.